Publications
23
Citations
2,105
Est. group size
~2
Recurring co-author estimate
Active years
7
Publishing since 2020
Sarah Karow's research focuses on evaluating how well vaccines and treatments work against serious respiratory infections such as COVID-19, influenza, and RSV (a common respiratory virus), primarily by studying hospitalized adult patients in the United States. This work also includes studies on sepsis (a life-threatening response to infection) treatment and long-term patient outcomes. The research relies on large observational studies and clinical data to measure real-world vaccine and drug effectiveness.
Publication output has been steady and consistent since 2020, averaging just over 3 papers per year over the last five years, with no clear signs of growth or decline.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Estimated Effectiveness of 2024-2025 COVID-19 Vaccination Against Severe COVID-19
JAMA Network Open · 2026
- RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons
JAMA · 2025
- Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study
Clinical Infectious Diseases · 2024
- Effectiveness of the Original Monovalent Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination Series Against Hospitalization for COVID-19–Associated Venous Thromboembolism
The Journal of Infectious Diseases · 2024
- Association of Vitamin C, Thiamine, and Hydrocortisone Infusion With Long-term Cognitive, Psychological, and Functional Outcomes in Sepsis Survivors
JAMA Network Open · 2023
- Vaccine Effectiveness Against Influenza A–Associated Hospitalization, Organ Failure, and Death: United States, 2022–2023
Clinical Infectious Diseases · 2023
- Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021–August 2022
Clinical Infectious Diseases · 2023
- Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults — United States, August–December 2021
MMWR Morbidity and Mortality Weekly Report · 2022
- Effectiveness of Monovalent mRNA Vaccines Against COVID-19–Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States — IVY Network, 18 States, December 26, 2021–August 31, 2022
MMWR Morbidity and Mortality Weekly Report · 2022
- Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022
Open Forum Infectious Diseases · 2022
- Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021
MMWR Morbidity and Mortality Weekly Report · 2021
- Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021
MMWR Morbidity and Mortality Weekly Report · 2021
- Effect of Vitamin C, Thiamine, and Hydrocortisone on Ventilator- and Vasopressor-Free Days in Patients With Sepsis
JAMA · 2021
- Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021
MMWR Morbidity and Mortality Weekly Report · 2021
- Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021
The Journal of Infectious Diseases · 2021
- MMWR Morbidity and Mortality Weekly Report×7
- JAMA×3
- JAMA Network Open×3
- Clinical Infectious Diseases×3
- The Journal of Infectious Diseases×2
- Rachel Martin‐Blais
Medicine · The Ohio State University
- Matthew C. Exline
Medicine · The Ohio State University
- Jaffar A. Al‐Tawfiq
Medicine · Indiana University
- Hadi M. Yassine
Medicine · Indiana University
- Jingyou Yu
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile